Methylphenidate and dextroamphetamine-induced peripheral vasculopathy

Journal of Clinical Rheumatology

Volumn 14, Issue 1, 2008, Pages 30-33

  Syed, Reema H ^a   Moore, Terry L ^a  

^a S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTINUCLEAR ANTIBODY; DEXAMPHETAMINE; FLUOXETINE; HISTONE ANTIBODY; IBUPROFEN; LORATADINE; METHYLPHENIDATE; ORAL CONTRACEPTIVE AGENT; CENTRAL STIMULANT AGENT;

ABSENCE OF SIDE EFFECTS; ACRAL CYANOSIS; ADULT; ALOPECIA; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ANXIETY DISORDER; ARTHRALGIA; ARTICLE; ATTENTION DEFICIT DISORDER; CALCINOSIS; CASE REPORT; CHILD; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CYANOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ERYTHEMA; FATIGUE; FEMALE; FEVER; HISTOPATHOLOGY; HUMAN; IMMUNOFLUORESCENCE TEST; LEUKOCYTOCLASTIC VASCULITIS; LIVEDO RETICULARIS; LUNG CANCER; LYMPHOCYTIC INFILTRATION; MORNING STIFFNESS; MYALGIA; NAIL DISEASE; NECROSIS; NECROTIZING ARTERITIS; OVARY CANCER; PAIN; PARESTHESIA; PERIPHERAL VASCULAR DISEASE; PHOTOSENSITIVITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PRURITUS; RAYNAUD PHENOMENON; RECURRENT DISEASE; SCHOOL CHILD; SHOOTING PAIN; SJOEGREN SYNDROME; SKIN BIOPSY; SKIN DISCOLORATION; SKIN ULCER; SYMPTOM; TELANGIECTASIA; THROMBOEMBOLISM; TREATMENT DURATION; VEIN THROMBOSIS; CHEMICALLY INDUCED DISORDER;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DEXTROAMPHETAMINE; FEMALE; HUMANS; LIVEDO RETICULARIS; METHYLPHENIDATE; PERIPHERAL VASCULAR DISEASES; RAYNAUD DISEASE;

EID: 44449102705     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181639aaa     Document Type: Article

References (12)

1. Van Den Hazel P, Zuurbier M, Babisch W, et al. Today's epidemics in children: possible relations to environmental pollution and suggested preventive measures. Acta Paediatr Suppl. 2006;95:18-25.
2. Jefferson HJ, Jayne DR. Peripheral vasculopathy and nephropathy in association with phentermine. Nephrol Dial Transplant. 1999;14:1761-1763.
3. Kokkinos J, Levine SR. Possible association of ischemic stroke with phenteramine. Stroke. 1993;24:310-313.
4. Cantu C, Arauz A, Murillo-Bonilla LM, et al. Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs. Stroke. 2003;34:1667-1673.
5. Sadeghian H. Lacunar stroke associated with methylphenidate abuse. Can J Neurol Sci. 2004;31:109-111.
6. Challman TD, Lipsky JJ. Methylphenidate: its pharmacology and uses. Mayo Clin Proc. 2000;75:711-721.
7. Wall SC, Gu H, Rudnick G. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. Mol Pharmacol. 1995;47:544-550.
8. Thai DL, Yurasits LN, Rudolph GR, et al. Comparative pharmacokinetics and tissue distribution of the d-enantiomers of para-substituted methylphenidate analogs. Am Soc Pharmacol Exp Ther. 1999;27: 645-650.
9. Kotaki H, Nakazato F, Aoyama T, et al. Interaction in tissue distribution between methylphenidate and pemoline. I. Tissue distribution of methylphenidate and its metabolites in rat. Chem Pharm Bull (Tokyo). 1988;36:3190-3195.
10. Leithauser B, Langheinrich AC, Rau WS, et al. A 22-year-old woman with lower limb arteriopathy. Buerger's disease, or methamphetamineor cannabis-induced arteritis? Heart Vessels. 2005;20:39-43.
11. Bingham C, Beaman M, Nicholls AJ, et al. Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 2,4methylenedioxymethamphetamine ('eecstasy'). Nephrol Dial Transplant. 1998;13:2654-2655.
12. Rumbaugh CL, Fanf HC, Higgins RE, et al. Cerebral microvascular injury in experimental drug abuse. Invest Radiol. 1976;11:282-294.